| Dr Polyxeni Gudis, DO | |
|
211 Park St, Attleboro, MA 02703-3143 | |
| (508) 222-5200 | |
| (508) 023-6733 |
| Full Name | Dr Polyxeni Gudis |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 5 Years |
| Location | 211 Park St, Attleboro, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275190993 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sturdy Memorial Hospital | Attleboro, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sturdy Memorial Associates Inc | 9537152806 | 177 |
News Archive
Surgery Center Holdings Inc. ("Surgery Partners" or "The Company"), a portfolio company of H.I.G. Capital, LLC ("H.I.G."), and Symbion Holdings Corporation ("Symbion"), a portfolio company of Crestview Partners, have announced that they have entered into a definitive merger agreement under which Surgery Partners will acquire 100% of the stock of Symbion for a total purchase price of $792 million.
Opioid use and abuse is a significant social, health and economic issue in Canada. Researchers at the University of Calgary's Faculty of Veterinary Medicine and Hotchkiss Brain Institute have discovered that an existing anti-gout medication is effective in reducing the severity of withdrawal symptoms in opioid-dependent rodents.
Specialty hospitals provide quality care to patients by offering new choices, and this hospital competition should not be stifled, the American Medical Association (AMA) testified to a subcommittee of the Senate Committee on Homeland Security and Governmental Affairs this week.
A new engineering solution may help deliver tumor killing drugs directly to the brain tumor without the toxic body effects of systemic chemotherapy. The new study published in the journal Nature Scientific Reports reports on the use of coaxial electrospinning, an industrial fabrication technology, in the production of membranes that incorporate drugs to treat glioblastoma multiforme (GBM), an aggressive cancer of the brain.
› Verified 6 days ago
| Entity Name | Sturdy Memorial Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063866176 PECOS PAC ID: 9537152806 Enrollment ID: O20160811001583 |
News Archive
Surgery Center Holdings Inc. ("Surgery Partners" or "The Company"), a portfolio company of H.I.G. Capital, LLC ("H.I.G."), and Symbion Holdings Corporation ("Symbion"), a portfolio company of Crestview Partners, have announced that they have entered into a definitive merger agreement under which Surgery Partners will acquire 100% of the stock of Symbion for a total purchase price of $792 million.
Opioid use and abuse is a significant social, health and economic issue in Canada. Researchers at the University of Calgary's Faculty of Veterinary Medicine and Hotchkiss Brain Institute have discovered that an existing anti-gout medication is effective in reducing the severity of withdrawal symptoms in opioid-dependent rodents.
Specialty hospitals provide quality care to patients by offering new choices, and this hospital competition should not be stifled, the American Medical Association (AMA) testified to a subcommittee of the Senate Committee on Homeland Security and Governmental Affairs this week.
A new engineering solution may help deliver tumor killing drugs directly to the brain tumor without the toxic body effects of systemic chemotherapy. The new study published in the journal Nature Scientific Reports reports on the use of coaxial electrospinning, an industrial fabrication technology, in the production of membranes that incorporate drugs to treat glioblastoma multiforme (GBM), an aggressive cancer of the brain.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Polyxeni Gudis, DO 211 Park St, Attleboro, MA 02703-3143 Ph: (508) 222-5200 | Dr Polyxeni Gudis, DO 211 Park St, Attleboro, MA 02703-3143 Ph: (508) 222-5200 |
News Archive
Surgery Center Holdings Inc. ("Surgery Partners" or "The Company"), a portfolio company of H.I.G. Capital, LLC ("H.I.G."), and Symbion Holdings Corporation ("Symbion"), a portfolio company of Crestview Partners, have announced that they have entered into a definitive merger agreement under which Surgery Partners will acquire 100% of the stock of Symbion for a total purchase price of $792 million.
Opioid use and abuse is a significant social, health and economic issue in Canada. Researchers at the University of Calgary's Faculty of Veterinary Medicine and Hotchkiss Brain Institute have discovered that an existing anti-gout medication is effective in reducing the severity of withdrawal symptoms in opioid-dependent rodents.
Specialty hospitals provide quality care to patients by offering new choices, and this hospital competition should not be stifled, the American Medical Association (AMA) testified to a subcommittee of the Senate Committee on Homeland Security and Governmental Affairs this week.
A new engineering solution may help deliver tumor killing drugs directly to the brain tumor without the toxic body effects of systemic chemotherapy. The new study published in the journal Nature Scientific Reports reports on the use of coaxial electrospinning, an industrial fabrication technology, in the production of membranes that incorporate drugs to treat glioblastoma multiforme (GBM), an aggressive cancer of the brain.
› Verified 6 days ago
Grant Goodrich, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 211 Park St, Attleboro, MA 02703 Phone: 508-236-8938 | |
Dr. Ianthe Anfone Arboleda, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 211 Park St, Attleboro, MA 02703 Phone: 508-222-5200 Fax: 508-236-7335 |